FR2342738B1 - - Google Patents

Info

Publication number
FR2342738B1
FR2342738B1 FR7605854A FR7605854A FR2342738B1 FR 2342738 B1 FR2342738 B1 FR 2342738B1 FR 7605854 A FR7605854 A FR 7605854A FR 7605854 A FR7605854 A FR 7605854A FR 2342738 B1 FR2342738 B1 FR 2342738B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7605854A
Other versions
FR2342738A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7605854A priority Critical patent/FR2342738A1/fr
Priority to ZA00771078A priority patent/ZA771078B/xx
Priority to JP2039977A priority patent/JPS52106855A/ja
Priority to AT136577A priority patent/AT355237B/de
Priority to CA272,894A priority patent/CA1082170A/fr
Priority to BE175355A priority patent/BE851944A/fr
Priority to NL7702166A priority patent/NL7702166A/xx
Priority to SE7702250A priority patent/SE7702250L/
Priority to AU22808/77A priority patent/AU509948B2/en
Priority to LU76867A priority patent/LU76867A1/xx
Priority to DK088277A priority patent/DK156401C/da
Priority to DE2709078A priority patent/DE2709078C2/de
Priority to GB8713/77A priority patent/GB1530975A/en
Priority to CH264177A priority patent/CH619969A5/fr
Priority to IE462/77A priority patent/IE44866B1/en
Priority to PT66261A priority patent/PT66261B/fr
Publication of FR2342738A1 publication Critical patent/FR2342738A1/fr
Application granted granted Critical
Publication of FR2342738B1 publication Critical patent/FR2342738B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7605854A 1976-03-02 1976-03-02 Nouveaux derives halogenes de la serie du 16a-methyl pregnane Granted FR2342738A1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR7605854A FR2342738A1 (fr) 1976-03-02 1976-03-02 Nouveaux derives halogenes de la serie du 16a-methyl pregnane
ZA00771078A ZA771078B (en) 1976-03-02 1977-02-23 New halogenated derivatives of the 16a-methyl pregnane series,process for preparing them and pharmaceutical compositions
JP2039977A JPS52106855A (en) 1976-03-02 1977-02-28 Novel halogenated derivatives of 16 alphaamethypregnane * preparation thereof and pharmaceutical composition
LU76867A LU76867A1 (fr) 1976-03-02 1977-03-01
BE175355A BE851944A (fr) 1976-03-02 1977-03-01 Nouveaux derives halogenes de la serie du 16-methyl pregnane
NL7702166A NL7702166A (nl) 1976-03-02 1977-03-01 Werkwijze voor de bereiding van 16(alpha)-methylpreg- naan-derivaten en van preparaten die ze bevat- ten.
SE7702250A SE7702250L (sv) 1976-03-02 1977-03-01 Sett att framstella nya halogenderivat i 16alfa-metylpregnanserien
AU22808/77A AU509948B2 (en) 1976-03-02 1977-03-01 Halogenated derivatives of 16 alphamethyl pregnant
AT136577A AT355237B (de) 1976-03-02 1977-03-01 Verfahren zur herstellung neuer halogenderivate in der reihe des 16 alpha- methylpregnans
DK088277A DK156401C (da) 1976-03-02 1977-03-01 Analogifremgangsmaade til fremstilling af halogenderivater af 16 alpha-methyl-pregnanraekken
CA272,894A CA1082170A (fr) 1976-03-02 1977-03-01 Procede de preparation de nouveau derives halogenes de la serie du 16 .alpha.-methyl pregnane
DE2709078A DE2709078C2 (de) 1976-03-02 1977-03-02 Neue Halogen-Derivate der Reihe des 16α-Methylpregnans, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
GB8713/77A GB1530975A (en) 1976-03-02 1977-03-02 Halogenated derivatives of the 16alpha-methylpregnane series processes for preparing them and pharmaceutical compositions containing them
CH264177A CH619969A5 (en) 1976-03-02 1977-03-02 Process for the preparation of new halogenated derivatives of the 16alpha-methylpregnane series
IE462/77A IE44866B1 (en) 1976-03-02 1977-03-02 New halogenated derivatives of the 16a-methylpregnane series,processes for preparing them and pharmaceutical compositions containing them
PT66261A PT66261B (fr) 1976-03-02 1977-03-02 Serie du 16alpha-methyl pregnane procede de preparation de nouveaux derives halogenes de la

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7605854A FR2342738A1 (fr) 1976-03-02 1976-03-02 Nouveaux derives halogenes de la serie du 16a-methyl pregnane

Publications (2)

Publication Number Publication Date
FR2342738A1 FR2342738A1 (fr) 1977-09-30
FR2342738B1 true FR2342738B1 (fr) 1979-10-12

Family

ID=9169832

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7605854A Granted FR2342738A1 (fr) 1976-03-02 1976-03-02 Nouveaux derives halogenes de la serie du 16a-methyl pregnane

Country Status (16)

Country Link
JP (1) JPS52106855A (fr)
AT (1) AT355237B (fr)
AU (1) AU509948B2 (fr)
BE (1) BE851944A (fr)
CA (1) CA1082170A (fr)
CH (1) CH619969A5 (fr)
DE (1) DE2709078C2 (fr)
DK (1) DK156401C (fr)
FR (1) FR2342738A1 (fr)
GB (1) GB1530975A (fr)
IE (1) IE44866B1 (fr)
LU (1) LU76867A1 (fr)
NL (1) NL7702166A (fr)
PT (1) PT66261B (fr)
SE (1) SE7702250L (fr)
ZA (1) ZA771078B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT385996B (de) * 1982-10-05 1988-06-10 Roussel Uclaf Verfahren zur herstellung neuer dichlorierter derivate aus der reihe der 16alpha -methylpregnane

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB928301A (en) * 1958-06-20 1963-06-12 Scherico Ltd 9, 11-dihalogeno steroids
US3049554A (en) * 1959-06-01 1962-08-14 Schering Corp 9, 11-dihalogeno-3, 20-diketopregnanes and processes for their manufacture

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT385996B (de) * 1982-10-05 1988-06-10 Roussel Uclaf Verfahren zur herstellung neuer dichlorierter derivate aus der reihe der 16alpha -methylpregnane

Also Published As

Publication number Publication date
ATA136577A (de) 1979-07-15
DE2709078A1 (de) 1977-09-08
JPS52106855A (en) 1977-09-07
AU2280877A (en) 1978-09-07
DK156401C (da) 1990-01-08
DK156401B (da) 1989-08-14
CH619969A5 (en) 1980-10-31
IE44866B1 (en) 1982-04-21
AU509948B2 (en) 1980-06-05
SE7702250L (sv) 1977-09-03
PT66261B (fr) 1979-01-17
GB1530975A (en) 1978-11-01
LU76867A1 (fr) 1977-09-26
CA1082170A (fr) 1980-07-22
BE851944A (fr) 1977-09-01
ZA771078B (en) 1978-04-26
FR2342738A1 (fr) 1977-09-30
IE44866L (en) 1977-09-02
JPS6150960B2 (fr) 1986-11-06
NL7702166A (nl) 1977-09-06
DK88277A (da) 1977-09-03
PT66261A (fr) 1977-04-01
DE2709078C2 (de) 1986-09-11
AT355237B (de) 1980-02-25

Similar Documents

Publication Publication Date Title
DE2724687C2 (fr)
JPS5621142B2 (fr)
DE2623387C2 (fr)
DE2651486C2 (fr)
FR2342738B1 (fr)
JPS52150276U (fr)
FR2361858B1 (fr)
JPS5348056U (fr)
JPS52168014U (fr)
JPS52126237U (fr)
JPS52103313U (fr)
JPS52100653U (fr)
JPS51129345U (fr)
JPS5323748U (fr)
JPS5338845U (fr)
JPS5353525U (fr)
JPS5355634U (fr)
CS177776B1 (fr)
CS177789B1 (fr)
CS178345B1 (fr)
DD127085A2 (fr)
DD124182A1 (fr)
DD127401A1 (fr)
DD127513A1 (fr)
DD127353A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse